Donoghue Forlines’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,807
Closed -$247K 239
2024
Q2
$247K Buy
1,807
+10
+0.6% +$1.39K 0.07% 208
2024
Q1
$275K Buy
+1,797
New +$268K 0.08% 208
2023
Q3
Sell
-2,239
Closed -$356K 228
2023
Q2
$356K Buy
2,239
+816
+57% +$132K 0.11% 201
2023
Q1
$225K Buy
+1,423
New +$213K 0.08% 202
2022
Q4
Sell
-4,735
Closed -$608K 232
2022
Q3
$608K Sell
4,735
-330
-7% -$47.6K 0.22% 82
2022
Q2
$714K Sell
5,065
-693
-12% -$99K 0.19% 136
2022
Q1
$801K Buy
5,758
+2,142
+59% +$328K 0.17% 188
2021
Q4
$630K Buy
+3,616
New +$603K 0.11% 206
2021
Q3
Sell
-3,410
Closed -$613K 208
2021
Q2
$613K Buy
+3,410
New +$622K 0.11% 170
2020
Q3
Sell
-6,688
Closed -$1.47M 122
2020
Q2
$1.47M Buy
+6,688
New +$1.34M 0.38% 37
2019
Q1
Sell
-16,104
Closed -$2.48M 124
2018
Q4
$2.48M Buy
+16,104
New +$2.51M 0.22% 24

Other funds holding CLX

Donoghue Forlines's CLX Position: Q3 2024 in Review

Donoghue Forlines sold out of Clorox (CLX) in Q3 2024, closing a stake of 1,807 shares — an estimated $247K sold.

Donoghue Forlines first reported a position in CLX in Q4 2018 and held it in 11 quarters. The position peaked at $2.48M in Q4 2018. 1,152 funds tracked by Wall St. Rank hold CLX as of Q3 2024.

  • Donoghue Forlines reported no remaining Clorox position as of Q3 2024 after selling out during the quarter.
  • Donoghue Forlines sold 1,807 Clorox shares in Q3 2024, an estimated $247K.
  • Donoghue Forlines first reported a position in Clorox in Q4 2018 and held it in 11 quarters.
  • Donoghue Forlines's Clorox position peaked at $2.48M in Q4 2018.
  • 1,152 funds tracked by Wall St. Rank held Clorox as of Q3 2024.

Based on Donoghue Forlines's 13F filing for Q3 2024, filed 13 Nov 2024.